Tag Archives: ADC Therapy

02Jul/23

ADC Change: The Re-evolution of Treatment Patterns

July 2, 2023ReviewADC Therapybioadc

Reviewing the 100-year development history of tumor therapy, it has gone through three revolutions, and also led to the revolution of chemotherapy, targeted therapy. and immunotherapy. It can be said that changeRead More…

24Nov/21

Ushering in a “Raging” Era—Fiercely Competitive Phase III ADCs (part I)

November 24, 2021ReviewADC Therapy, CEACAM5, DM4, Phase III ADCsbioadc

An antibody-drug conjugate (ADC) is composed of an antibody, a chemical linker, and a small molecular payload, and takes advantage of the specific targeting binding ability of antibody to transport cytotoxic payloadRead More…

Home
Antibody-drug Conjugates Research
Antibody-drug Conjugates Manufacturing
News